Slippery Slope: Is a Surrogate Endpoint Evidence of Efficacy? (CME/CE)

(MedPage Today) -- In this new series MedPage Today/Milwaukee Journel Sentinel investigate the decisions made by the FDA starting with its approval of around 50 novel cancer drugs. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1tVzOID